Prospective Multicentric Randomized Study Comparing Periareolar and Peritumoral Injection of Radiotracer and Blue Dye for the Detection of Sentinel Lymph Node in Breast Sparing Procedures: FRANSENODE Trial
- 20 August 2007
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 25 (24) , 3664-3669
Abstract
Purpose To determine the optimal injection path for blue dye and radiocolloid for sentinel lymph node (SLN) biopsy in early breast cancer. Patients and Methods A prospective randomized multicentric study was initiated to compare the peritumoral (PT) injection site to the periareolar (PA) site in 449 patients. Results The detection rate of axillary SLN by lymphoscintigraphy was significantly higher (P = .03) in the PA group (85.2%) than in the PT group (73.2%). Intraoperative detection rate by blue dye and/or gamma probe was similar (99.11%) in both groups. The rate of SLN detection was somewhat higher in the PA group than in the PT group: 95.6% versus 93.8% with blue dye (P = .24) and 98.2% versus 96.0% by probe (P = .16), respectively. The number of SLNs detected by lymphoscintigraphy and by probe was significantly higher in the PA group than in the PT group, 1.5 versus 1.2 (P = .001) and 1.9 versus 1.7 (P = .02). The blue and hot concordance was 95.6% in the PA group and 91.5% in the PT group (P = .08). The mean ex vivo count of the SLN was significantly higher in the PA group than in the PT group (P < .0001). Conclusion This study strongly validates the PA injection technique given the high detection rate (99.1%) of SLN and the high concordance (95.6%) between blue dye and the radiotracer, as well as higher significant ex and in vivo counts, improving SLN probe detection.Keywords
This publication has 32 references indexed in Scilit:
- Experience with intradermal injection and intradermal-plus-deep injection in the radioguided sentinel node biopsy of early breast cancer patientsEuropean Journal of Surgical Oncology, 2006
- Prospective Randomized Clinical Trial Comparing Intradermal, Intraparenchymal, and Subareolar Injection Routes for Sentinel Lymph Node Mapping and Biopsy in Breast CancerAnnals of Surgical Oncology, 2006
- Letter to the editor concerning ‘intradermal radioisotope injection optimises sentinel lymph node identification in breast cancer’European Journal of Surgical Oncology, 2004
- Rationale for superficial injection techniques in lymphatic mapping in breast cancer patientsJournal of Surgical Oncology, 2004
- Intradermal radioisotope injection is superior to subdermal injection for the identification of the sentinel node in breast cancer patientsJournal of Surgical Oncology, 2003
- Reply: Breast Lymphatic Mapping Using Blue Dye and RadiocolloidJournal of the American College of Surgeons, 2002
- Dermal Versus Intraparenchymal Lymphoscintigraphy of the BreastAnnals of Surgical Oncology, 2001
- Intradermal Isotope Injection: A Highly Accurate Method of Lymphatic Mapping in Breast CarcinomaAnnals of Surgical Oncology, 2001
- Preoperative Lymphoscintigraphy During Lymphatic Mapping for Breast Cancer: Improved Sentinel Node Imaging Using Subareolar Injection of Technetium 99M Sulfur ColloidJournal of the American College of Surgeons, 2000
- Lymphatic mapping with intralesional tracer administration in breast carcinoma patientsCancer, 2000